BIOQUAL, Inc.
BIOQ
$55.00
-$1.00-1.79%
| 11/30/2024 | 08/31/2024 | 11/30/2023 | 11/30/2023 | 05/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.21M | -675.30K | 484.70K | 484.70K | -702.10K |
| Total Depreciation and Amortization | -366.30K | 1.58M | -255.00K | -255.00K | 4.19M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.56M | -- | 1.84M | 1.84M | -2.66M |
| Change in Net Operating Assets | -4.09M | -2.27M | 2.28M | 2.28M | 2.87M |
| Cash from Operations | -2.11M | -1.37M | 4.35M | 4.35M | 3.69M |
| Capital Expenditure | -13.50K | -187.60K | -177.30K | -177.30K | -777.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 2.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -13.50K | -187.60K | -177.30K | -177.30K | -775.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -447.20K | -- | -447.20K | -447.20K | 0.00 |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -447.20K | -- | -447.20K | -447.20K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.57M | -1.56M | 3.73M | 3.73M | 2.92M |
